View Item 

Show simple item record

Utilization of Genetic Counseling after Direct‐to‐Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study
dc.contributor.authorKoeller, Diane R
dc.contributor.authorUhlmann, Wendy R
dc.contributor.authorCarere, Deanna Alexis
dc.contributor.authorGreen, Robert C
dc.contributor.authorRoberts, J Scott
dc.date.accessioned2019-01-15T20:27:05Z
dc.date.available2019-01-15T20:27:05Z
dc.date.issued2017-12
dc.identifier.citationKoeller, Diane R; Uhlmann, Wendy R; Carere, Deanna Alexis; Green, Robert C; Roberts, J Scott (2017). "Utilization of Genetic Counseling after Direct‐to‐Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study." Journal of Genetic Counseling 26(6): 1270-1279.
dc.identifier.issn1059-7700
dc.identifier.issn1573-3599
dc.identifier.urihttps://hdl.handle.net/2027.42/146977
dc.description.abstractDirect‐to‐consumer personal genomic testing (DTC‐PGT) results lead some individuals to seek genetic counseling (GC), but little is known about these consumers and why they seek GC services. We analyzed survey data pre‐ and post‐PGT from 1026 23andMe and Pathway Genomics customers. Participants were mostly white (91%), female (60%), and of high socioeconomic status (80% college educated, 43% household income of ≥$100,000). After receiving PGT results, 43 participants (4%) made or planned to schedule an appointment with a genetic counselor; 390 (38%) would have used in‐person GC had it been available. Compared to non‐seekers, GC seekers were younger (mean age of 38 vs 46 years), more frequently had children <18 (26% vs 16%), and were more likely to report previous GC (37% vs 7%) and genetic testing (30% vs 15%). In logistic regression analysis, seeking GC was associated with previous GC use (OR = 6.5, CI = 3.1–13.8), feeling motivated to pursue DTC‐PGT for health reasons (OR = 4.3, CI = 1.8–10.1), fair or poor self‐reported health (OR = 3.1, CI = 1.1–8.3), and self‐reported uncertainty about the results (OR = 1.8, CI = 1.1–2.7). These findings can help GC providers anticipate who might seek GC services and plan for clinical discussions of DTC‐PGT results.
dc.publisherSpringer US
dc.publisherWiley Periodicals, Inc.
dc.subject.otherGenetic counseling
dc.subject.otherPersonalized medicine
dc.subject.otherGenetic counselors
dc.subject.otherPersonal genomic testing
dc.subject.otherDirect‐to‐consumer
dc.subject.otherGenetic testing
dc.subject.otherDTC
dc.subject.otherHealth behavior
dc.titleUtilization of Genetic Counseling after Direct‐to‐Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHuman Genetics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146977/1/jgc41270.pdf
dc.identifier.doi10.1007/s10897-017-0106-7
dc.identifier.sourceJournal of Genetic Counseling
dc.identifier.citedreferenceMathews, R., Hall, W., & Carter, A. ( 2012 ). Direct‐to‐consumer genetic testing for addiction susceptibility: A premature commercialisation of doubtful validity and value. Addiction, 107 ( 12 ), 2069 – 2074. doi:10.1111/j.1360‐0443.2012.03836.x.
dc.identifier.citedreferenceDohany, D., Gustafson, S., Ducaine, W., & Zakalik, D. ( 2012 ). Psychological distress with direct‐toconsumer genetic testing: a case report of an unexpected BRCA positibe test result. Journal of Genetic Counseling, 21 ( 3 ), 399 – 401.
dc.identifier.citedreferenceFood & Drug Administration. ( 2017 ). FDA allows marketing offirst direct‐to‐consumer tests that provide genetic risk information for certain conditions. Retrieved from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm551185.htm.
dc.identifier.citedreferenceFrancke, U., Dijamco, C., Kiefer, A. K., Eriksson, N., Moiseff, B., Tung, J. Y., & Mountain, J. L. ( 2013 ). Dealing with the unexpected: consumer responses to direct‐access BRCA mutation testing. PeerJ, 1, e8. doi:10.7717/peerj.8.
dc.identifier.citedreferenceFurr, L. A., & Kelly, S. E. ( 1999 ). The genetic knowledge index: Developing a standard measure of genetic knowledge. Genetic Testing, 3 ( 2 ), 193 – 199. doi:10.1089/gte.1999.3.193.
dc.identifier.citedreferenceGutierrez, A. ( 2013 ). Warning Letter. Retrieved from http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm376296.htm.
dc.identifier.citedreferenceHarris, A., Kelly, S. E., & Wyatt, S. ( 2013 ). Counseling customers: Emerging roles for genetic counselors in the direct‐to‐consumer genetic testing market. Journal of Genetic Counseling, 22 ( 2 ), 277 – 288. doi:10.1007/s10897‐012‐9548‐0.
dc.identifier.citedreferenceHock, K. T., Christensen, K. D., Yashar, B. M., Roberts, J. S., Gollust, S. E., & Uhlmann, W. R. ( 2011 ). Direct‐to‐consumer genetic testing: An assessment of genetic counselors’ knowledge and beliefs. Genetics in Medicine, 13 ( 4 ), 325 – 332. doi:10.1097/GIM.0b013e3182011636.
dc.identifier.citedreferenceHudson, K., Javitt, G., Burke, W., Byers, P., & ASHG Social Issues Committee. ( 2007 ). ASHG Statement on Direct‐to‐Consumer Genetic Testing in the United States. American Journal of Human Genetics, 81 ( 3 ), 635 – 637.
dc.identifier.citedreferenceJames, K. M., Cowl, C. T., Tilburt, J. C., Sinicrope, P. S., Robinson, M. E., Frimannsdottir, K. R., et al. ( 2011 ). Impact of direct‐to‐consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clinic Proceedings, 86 ( 10 ), 933 – 940. doi:10.4065/mcp.2011.0190.
dc.identifier.citedreferenceKalf, R. R. J., Mihaescu, R., Kundu, S., Knijff, P. D., Green, R C., & Janssens, A. C. J. ( 2014 ). Variations in predicted risks in personal genome testing for common complex diseases. Genetics in Medicine, 16 ( 1 ), 1 – 13. doi:10.1038/gim.2013.80.Variations.
dc.identifier.citedreferenceKaufman, D. J., Bollinger, J. M., Dvoskin, R. L., & Scott, J. A. ( 2012 ). Risky business: Risk perception and the use of medical services among customers of DTC personal genetic testing. Journal of Genetic Counseling, 21 ( 3 ), 413 – 422. doi:10.1007/s10897‐012‐9483‐0.
dc.identifier.citedreferenceLehmann, L. S., Kaufman, D. J., Sharp, R. R., Moreno, T. A., Mountain, J. L., Roberts, J. S., & Green, R. C. ( 2012 ). Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 14 ( 2 ), 268 – 273. doi:10.1038/gim.2011.59.
dc.identifier.citedreferenceLeighton, J. W., Valverde, K., & Bernhardt, B. A. ( 2012 ). The general public’s understanding and perception of direct‐to‐consumer genetic test results. Public Health Genomics, 15 ( 1 ), 11 – 21. doi:10.1159/000327159.
dc.identifier.citedreferenceLipkus, I. M., Samsa, G., & Rimer, B. K. ( 2001 ). General performance on a numeracy scale among highly educated samples. Medical Decision Making, 21, 37 – 44.
dc.identifier.citedreferenceMeisel, S. F., Carere, D. A., Wardle, J., Kalia, S. S., Moreno, T. A., Mountain, J. L., et al. ( 2015 ). Explaining, not just predicting, drives interest in personal genomics. Genome Medicine, 7 ( 1 ), 74. doi:10.1186/s13073‐015‐0188‐5.
dc.identifier.citedreferenceMolster, C., Charles, T., Samanek, A., & O’Leary, P. ( 2009 ). Australian study on public knowledge of human genetics and health. Public Health Genomics, 12 ( 2 ), 84 – 91. doi:10.1159/000164684.
dc.identifier.citedreferenceNSGC Executive Office. ( 2015 ). Direct Access to Genetic Testing. Retrieved from http://nsgc.org/p/bl/et/blogid=47&blogaid=22.
dc.identifier.citedreferenceOstergren, J. E., Gornick, M. C., Carere, D. A., Kalia, S. S., Uhlmann, W. R., Ruffin, M. T., et al. ( 2015 ). How well do customers of direct‐to‐consumer personal genomic testing services comprehend genetic test results? Findings from the impact of personal genomics study for the PGen study group. Public Health Genomics, 18 ( 4 ), 216 – 224. doi: 10.1159/000431250.
dc.identifier.citedreferencePowell, K. P., Christianson, C. A., Cogswell, W. A., Dave, G., Verma, A., Eubanks, S., & Henrich, V. C. ( 2012 ). Educational needs of primary care physicians regarding direct‐to‐consumer genetic testing. Journal of Genetic Counseling, 21 ( 3 ), 469 – 478. doi:10.1007/s10897‐011‐9471‐9.
dc.identifier.citedreferenceRoberts, J. S., & Ostergren, J. ( 2013 ). Direct‐to‐consumer genetic testing and personal genomics services: A review of recent empirical studies. Current Genetic Medicine Reports, 1 ( 3 ), 182 – 200. doi:10.1007/s40142‐013‐0018‐2.
dc.identifier.citedreferenceSmerecnik, C. M. R., Mesters, I., De Vries, N. K., & De Vries, H. ( 2011 ). Applying a theory‐based framework to understand public knowledge of genetic risk factors: A case for the distinction between how‐to knowledge and principles knowledge. Public Health Genomics, 14 ( 4–5 ), 259 – 270. doi:10.1159/000294149.
dc.identifier.citedreferenceUhlmann, W. R., & Sharp, R. R. ( 2012 ). Genetic testing integration panels (GTIPs): A novel approach for considering integration of direct‐to‐consumer and other new genetic tests into patient care. Journal of Genetic Counseling, 21 ( 3 ), 374 – 381. doi:10.1007/s10897‐011‐9468‐4.
dc.identifier.citedreferencevan der Wouden, C. H., Carere, D. A., Maitland‐van der Zee, A. H., Ruffin, M. T., Roberts, J. S., & Green, R. C. ( 2016 ). Consumer perceptions of interactions with primary care providers after direct‐to‐consumer personal genomic testing. Annals of Internal Medicine. doi: 10.7326/M15‐0995.
dc.identifier.citedreferenceWade, C. H., & Wilfond, B. S. ( 2006 ). Ethical and clinical practice con‐siderations for genetic counselors related to direct‐to‐Consuemr Marketing of Genetic Tests. American Journal of Medical Genetics Part C, 142C, 284 – 292. doi:10.1002/ajmg.c.
dc.identifier.citedreferenceWare, J., & Sherbourne, C. ( 1992 ). The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care, 30 ( 6 ), 473 – 483.
dc.identifier.citedreferenceWasson, K., Cherny, S., Sanders, T. N., Hogan, N. S., & Helzlsouer, K. J. ( 2014 ). Who are you going to call? Primary care patients’ disclosure decisions regarding direct‐to‐consumer genetic testing. Narrative Inquiry in Bioethics, 4 ( 1 ), 53 – 68. doi:10.1353/nib.2014.0026.
dc.identifier.citedreferenceACMG Board of Directors. ( 2015 ). Direct‐to‐consumer genetic testing: A revised position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine, 18 ( 2 ), 207 – 208. doi: 10.1038/gim.2015.190.
dc.identifier.citedreferenceAshida, S., Goodman, M. S., Stafford, J., Lachance, C., & Kaphingst, K. A. ( 2012 ). Perceived familiarity with and importance of family health history among a medically underserved population. Journal of Community Genetics, 3 ( 4 ), 285 – 295. doi:10.1007/s12687‐012‐0097‐x.
dc.identifier.citedreferenceBloss, C. S., Darst, B. F., Topol, E. J., & Schork, N. J. ( 2011 ). Direct‐to‐consumer personalized genomic testing. Human Molecular Genetics, 20 ( R2 ), R132 – R141. doi:10.1093/hmg/ddr349.
dc.identifier.citedreferenceBloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. ( 2013 ). Impact of direct‐to‐consumer genomic testing at long term follow‐up. Journal of Medical Genetics, 50 ( 6 ), 393 – 400. doi:10.113 6/jmedgenet‐2012‐101207.
dc.identifier.citedreferenceBowling, B. V., Acra, E. E., Wang, L., Myers, M. F., Dean, G. E., Markle, G. C., et al. ( 2008 ). Development and evaluation of a genetics literacy assessment instrument for undergraduates. Genetics, 178 ( 1 ), 15 – 22. doi:10.1534/genetics.107.079533.
dc.identifier.citedreferenceBunnik, E. M., Janssens, A. C. J. W., & Schermer, M. H. N. ( 2015 ). Personal utility in genomic testing: Is there such a thing? Journal of Medical Ethics, 41 ( 4 ), 322 – 326. doi:10.1136/medethics‐2013‐101887.
dc.identifier.citedreferenceCarere, D. A., Couper, M. P., Crawford, S. D., Kalia, S. S., Duggan, J. R., Moreno, T. A., et al. ( 2014 ). Design, methods, and participant char‐acteristics of the impact of personal genomics (PGen) study, a pro‐spective cohort study of direct‐to‐consumer personal genomic testing customers. Genome Medicine, 6 ( 12 ), 96. doi:10.1186/s13073‐014‐0096‐0.
dc.identifier.citedreferenceCarere, D. A., Kraft, P., Kaphingst, K. A., Roberts, J. S., & Green, R. C. ( 2016 ). Consumers report lower confidence in their genetics knowledge following direct‐to‐consumer personal genomic testing. Genetics in Medicine, 18 ( 1 ), 65 – 72. doi:10.1038/gim.2015.34.
dc.identifier.citedreferenceCaulfield, T., & McGuire, A. L. ( 2012 ). Direct‐to‐consumer genetic testing: Perceptions, problems, and policy responses. Annual Review of Medicine, 63, 23 – 33. doi:10.1146/annurev‐med‐062110‐123753.
dc.identifier.citedreferenceChung, S., Mehta, K., Shumway, M., Alvidrez, J., & Perez‐Stable, E. J. ( 2009 ). Risk perception and preference for prevention of Alzheimer’s disease. Value in Health, 12 ( 4 ), 450 – 458. doi:10.14440/jbm.2015.54.A.
dc.identifier.citedreferenceDarst, B. F., Madlensky, L., Schork, N. J., Topol, E. J., & Bloss, C. S. ( 2013 ). Perceptions of genetic counseling services in direct‐to‐consumer personal genomic testing. Clinical Genetics, 84 ( 4 ), 335 – 339. doi:10.1111/cge.12166.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgc41270.pdf
Size:
442.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.